Live
- Medical devices sector needs separate rules, says industry body AiMeD
- Opposition INDIA bloc working on 'one year, one PM' formula: PM Modi
- Delhi HC quashes FIR for outraging woman's modesty, orders man to assist Traffic Police for a month as settlement
- 'Apologise to families of farmers who committed suicide in Vidarbha', Amit Shah dares Sharad Pawar
- SC Collegium recommends appointment of a permanent judge in Chhattisgarh HC, extension of term of two judges
- U20 Men's football nationals: Telangana, Sikkim earn full points with easy win
- SEBI probes 2 funds for shorting Adani stocks before Hindenburg
- Kerala Governor Arif Mohammed Khan visits Prashanti Nilayam
- All people should Co-operate for free and fair elections
- "Audiences in the South will appreciate a story that smashes the stereotype of weak and meek women," says Yatin Karyekar
Covaxin neutralises UK variant of Covid: Study
Second dose of covaxin to be distributed from today in the state
Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study.
Hyderabad: Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study.
According to a research paper carried by bioRxiv, the preprint server for biology, the study has dispelled the uncertainty of possible neutralisation escape.
A group of researchers from Indian Council of Medical Research(ICMR), National Institute of Virology, Pune and Bharat Biotech performed the plaque reduction neutralization test (PRNT50) using sera collected from the 26 recipients of BBV152/Covaxin against hCoV-19/India/20203522 (UK-variant) and hCoV27 19/India/2020Q111 (heterologous strain).
